Clinical Trial Update: Robotic Subretinal tPA Injection Study [NA]

View source ↗

Summary

This clinical trial update reports the completion of a robotic subretinal tissue plasminogen activator (tPA) injection study. It investigates treatment for subr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Subretinal Hemorrhage

Drugs mentioned

• tPA (tissue plasminogen activator) (tissue plasminogen activator)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Subretinal Hemorrhage, Age-Related Macular Degeneration | NA | Status: COMPLETED